Addressing barriers to vaccine acceptance: an overview

Noni E. MacDonald, Robb Butler, Eve Dubé

Research output: Contribution to journalArticlepeer-review

113 Citations (Scopus)

Abstract

Addressing the drivers of vaccine hesitancy and the barriers to vaccine acceptance is a complex but important task. While the percentage of hesitant does vary from country to country and in time few, if any, countries are ever free from this problem. Overcoming hesitancy requires detection, diagnosis and tailored intervention as there is no simple strategy that can address all of the barriers to vaccine acceptance. Immunization program managers and health care workers need to become adept at recognizing and tackling hesitancy in all of its incarnations if high levels of vaccine acceptance are to be achieved but must also actively support immunization acceptors in order to build and support vaccine acceptance resiliency. This paper presents evidence-informed strategies to achieve these goals.

Original languageEnglish
Pages (from-to)218-224
Number of pages7
JournalHuman Vaccines and Immunotherapeutics
Volume14
Issue number1
DOIs
Publication statusPublished - Jan 2 2018

Bibliographical note

Publisher Copyright:
© 2018 Taylor & Francis.

ASJC Scopus Subject Areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Fingerprint

Dive into the research topics of 'Addressing barriers to vaccine acceptance: an overview'. Together they form a unique fingerprint.

Cite this

MacDonald, N. E., Butler, R., & Dubé, E. (2018). Addressing barriers to vaccine acceptance: an overview. Human Vaccines and Immunotherapeutics, 14(1), 218-224. https://doi.org/10.1080/21645515.2017.1394533